18,101 Shares in First Trust Nasdaq Pharmaceuticals ETF $FTXH Acquired by Englebert Financial Advisers LLC

Englebert Financial Advisers LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 18,101 shares of the company’s stock, valued at approximately $751,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Compass Financial Management LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the second quarter valued at approximately $29,000. Vivaldi Capital Management LP grew its position in First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock worth $433,000 after acquiring an additional 1,741 shares in the last quarter. MinichMacGregor Wealth Management LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the third quarter worth approximately $968,000. Nilsine Partners LLC grew its position in First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after acquiring an additional 937 shares in the last quarter. Finally, Trust Co. of Oklahoma acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth $1,283,000.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 2.7%

Shares of FTXH opened at $42.70 on Wednesday. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45. The company’s fifty day moving average is $41.30 and its 200-day moving average is $37.98. First Trust Nasdaq Pharmaceuticals ETF has a 12 month low of $29.25 and a 12 month high of $43.52.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Thursday, September 24th were paid a $0.0113 dividend. This represents a $0.05 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Thursday, September 24th. This is a drop from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920.

First Trust Nasdaq Pharmaceuticals ETF Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.